Search

All phases Early Phase 1 Phase 1 Phase 2 Phase 3 Phase 4 Phase 1/2 Phase 2/3

All statuses Open (recruiting or opening soon) Active, not recruiting Completed

25 miles 50 miles 100 miles 200 miles

Newest Nearest Most relevant

Apply Reset

An Extension of Istradefylline in Parkinson's Disease Patients Who Have Completed Studies 6002-EU-007, 6002-US-013 or 6002-US-018

Trial Phase 3 Completed April 24, 2024

12-Week, Double-Blind, Placebo-Controlled Study of 20 and 60 mg/Day Istradefylline in Parkinson's Disease Patients on Levodopa/Carbodopa

Trial Phase 2 Completed April 24, 2024

Long Term Study of Istradefylline in Subjects With Moderate to Severe Parkinson's Disease

Trial Phase 3 Completed April 24, 2024

Effect of Continuous Apomorphine During the Night on Sleep Disorders in Insomniac Patients With Parkinson's Disease

Trial Phase 4 Completed April 24, 2024

Identification of a Biomarker Predictive of Evolution of Parkinson Disease

Trial Phase 2 Unknown April 24, 2024

12-Week, Double-Blind, Placebo-Controlled, Randomized Study of the Efficacy of 40 mg/Day KW-6002 in Parkinson's Disease Patients on Levodopa/Carbidopa

Trial Phase 2 Completed April 24, 2024

A Study of Istradefylline (KW-6002) as Monotherapy in Parkinson's Disease (PD) Patients

Trial Phase 2 Completed April 24, 2024

A 12-week Randomized Study to Evaluate Oral Istradefylline in Subjects With Moderate to Severe Parkinson's Disease

Trial Phase 3 Completed April 24, 2024

A Study of Istradefylline (KW-6002) in Treating Patients With Parkinson's Disease on Levodopa

Trial Phase 3 Completed April 24, 2024

A Long-Term, Safety Study With a Flexible Dose Range of KW-6002 in Patients With Motor Response Complications on Levodopa/Carbidopa Therapy

Trial Phase 2 Completed April 24, 2024

Keep On Keep Up for Parkinson's

Trial N/A Unknown April 23, 2024

Study to Assess the Safety, Tolerability and Preliminary Efficacy of NLX-112 Versus Placebo in L-dopa-induced Dyskinesia

Trial Phase 2 Completed April 22, 2024

Efficacy of Probiotics for Parkinson Disease (PD)

Trial N/A Withdrawn April 22, 2024

The Effect of Intranasal Insulin on Motor and Non-motor Symptoms in Parkinson's Disease Patients

Trial Phase 2 Completed April 22, 2024

BEAM: Brain-Eye Amyloid Memory Study

Trial N/A Unknown April 21, 2024

Mixed Music Intervention on Sleep Disturbance in Patients With Parkinson's Disease

Trial N/A Terminated April 21, 2024

Progression Follow up of the First-degree Relatives of Patients With REM Sleep Behavior Disorder

Trial N/A Unknown April 18, 2024

Gut Microbiota in the Progression of Alpha-synucleinopathies

Trial N/A Unknown April 18, 2024

Neural Correlates of Impulsivity in Idiopathic REM Sleep Behavior Disorder

Trial N/A Unknown April 18, 2024

Ocular Microtremor in Parkinson's Disease.

Trial N/A Unknown April 18, 2024